NR5A1/SF-1 Collaborates with Inhibin α and the Androgen Receptor
Steroidogenic factor 1 (SF-1) is a nuclear receptor that regulates steroidogenesis and reproductive development. <i>NR5A1</i>/SF-1 variants are associated with a broad spectrum of phenotypes across individuals with disorders of sex development (DSDs). Oligogenic inheritance has been suggested as an explanation. SF-1 interacts with numerous partners. Here, we investigated a constellation of gene variants identified in a 46,XY severely undervirilized individual carrying an ACMG-categorized 'pathogenic' <i>NR5A1</i>/SF-1 variant in comparison to the healthy carrier father. Candidate genes were revealed by whole exome sequencing, and pathogenicity was predicted by different in silico tools. We found variants in <i>NR1H2</i> and <i>INHA</i> associated with steroidogenesis, sex development, and reproduction. The identified variants were tested in cell models. Novel SF-1 and NR1H2 binding sites in the <i>AR</i> and <i>INHA</i> gene promoters were found. Transactivation studies showed that wild-type <i>NR5A1</i>/SF-1 regulates <i>INHA</i> and <i>AR</i> gene expression, while the <i>NR5A1</i>/SF-1 variant had decreased transcriptional activity. NR1H2 was found to regulate <i>AR</i> gene transcription; however, the NR1H2 variant showed normal activity. This study expands the <i>NR5A1</i>/SF-1 network of interacting partners, while not solving the exact interplay of different variants that might be involved in revealing the observed DSD phenotype. It also illustrates that understanding complex genetics in DSDs is challenging.
Authors
- Núria Camats (ORCID: https://orcid.org/0000-0002-4863-8201)
- Chrysanthi Kouri (ORCID: https://orcid.org/0000-0002-7225-593X)
- Idoia Martinez de la Piscina (ORCID: https://orcid.org/0000-0001-8943-1429)
- Rawda Naamneh Elzenaty (ORCID: https://orcid.org/0000-0003-2669-4170)
- Francisca Moreno
- Christa E. Flück
- Kay-Sara Sauter
Institutions
- University of Bern (CH)
- University Hospital of Bern (CH)
- Instituto de Salud Carlos III (ES)
- BioCruces Health research Institute (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hospital de Cruces (ES)
- Instituto de Investigación de Enfermedades Raras (ES)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2024-09-20
- DOI
- https://doi.org/10.3390/ijms251810109
- Citations
- 2
- Primary Topic
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Type
- article
- Field-Weighted Citation Impact
- 1.10
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Eusko Jaurlaritza